Volcano Corporation Announces Agreement To Acquire AtheroMed

Volcano Corporation (Nasdaq: VOLC) said today it has signed an agreement to acquire AtheroMed, Inc., a privately-held company that has developed the Phoenix® Atherectomy System used in the treatment of peripheral artery disease (PAD). The Phoenix, which received 510(k) clearance in January 2014 and has a CE Mark, enables physicians to treat PAD with a low profile peripheral atherectomy catheter that continuously removes diseased material as it is debulked. The device has reimbursement in the U.S. and select countries in Europe.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news